VANCOUVER, British Columbia (AP) _ Correvio Pharma Corp. (CORV) on Wednesday reported a loss of $9 million in its first quarter.
On a per-share basis, the Vancouver, British Columbia-based company said it had a loss of 23 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.
The cardiovascular drug maker posted revenue of $7.3 million in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $7.9 million.
The company's shares closed at $2.82. A year ago, they were trading at $2.30.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CORV at https://www.zacks.com/ap/CORV